2.55

4.51% 0.11

Allurion Technologies Inc (ALUR)

Overview News Price History Option Chain Discussions Forecast

Allurion Technologies Inc stock is traded at $2.55, with a volume of 90,393. It is up +4.51% in the last 24 hours and down -19.56% over the past month. Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Previous Close:

$2.44

Open:

$2.4

24h Volume:

90,393

Relative Volume:

0.06

Market Cap:

$20.21M

Revenue:

$34.75M

Net Income/Loss:

$-24.76M

P/E Ratio:

-0.2125

EPS:

-12

Net Cash Flow:

$-50.91M

1W Performance:

-5.90%

1M Performance:

-19.56%

6M Performance:

-67.65%

1Y Performance:

-90.89%

1-Day Range:

$2.40

$2.56

1-Week Range:

$2.40

$2.775

52-Week Range:

$2.15

$88.75

Allurion Technologies Inc Stock (ALUR) Company Profile

Name

Allurion Technologies Inc

Sector

Healthcare (1172)

Industry

Medical Devices (150)

Phone

508-647-4000

Address

11 HURON DR STE 200, NATICK

Employee

137

Twitter

Next Earnings Date

2024-12-13

Latest SEC Filings

ALUR's Discussions on Twitter

Compare ALUR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALUR Allurion Technologies Inc	2.55	20.21M	34.75M	-24.76M	-50.91M	-12.00
ABT Abbott Laboratories	132.28	233.36B	42.34B	13.50B	6.66B	7.71
SYK Stryker Corp	373.37	147.15B	23.22B	2.86B	3.58B	7.40
BSX Boston Scientific Corp	101.73	146.97B	17.55B	2.03B	2.72B	1.37
MDT Medtronic Plc	86.17	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	73.27	44.46B	5.54B	4.18B	623.10M	7.00

Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-24	Downgrade	Chardan Capital Markets	Buy → Neutral
Oct-02-24	Initiated	TD Cowen	Buy
Sep-06-24	Initiated	ROTH MKM	Buy
Feb-09-24	Initiated	Jefferies	Buy

Allurion Technologies Inc Stock (ALUR) Latest News

Jun 17, 2025

Major Weight Loss Breakthrough: 20,000 Patient Study Reveals Muscle-Preserving Success of Allurion Program - Stock Titan

Jun 17, 2025

Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS - New Castle News

Jun 17, 2025

Jun 16, 2025

Allurion Technologies Inc. (NYSE:ALUR) Short Interest Down 42.4% in May - Defense World

Jun 16, 2025

Jun 11, 2025

(ALUR) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 11, 2025

Jun 10, 2025

Allurion Technologies (NYSE:ALUR) Trading 2.1% Higher – Time to Buy? - Defense World

Jun 10, 2025

Jun 04, 2025

Allurion at Jefferies Conference: Strategic US Market Entry By Investing.com - Investing.com South Africa

Jun 04, 2025

Allurion at Jefferies Conference: Strategic US Market Entry - Investing.com Australia

Jun 04, 2025

May 29, 2025

October's 4 Best Penny Stocks: High-Risk, High-Reward Picks - The Globe and Mail

May 29, 2025